1. Home
  2. Clinical Topics
  3. Cardio-Pulmonary
  4. FDA allows marketing of first system to repair failed or problematic aortic endografts
Cardio-PulmonaryClinical TopicsDrugs and DevicesHealthcare & TechnologyNewsWeb Exclusives

FDA allows marketing of first system to repair failed or problematic aortic endografts

Share

The U.S. Food and Drug Administration is allowing marketing of the first system—a minimally invasive option—that can repair a failed or problematic aortic endograft. Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts